# Myopia.website

> English-language knowledge resource dedicated to myopia, its development, diagnosis, monitoring, progression, treatment strategies and scientific evidence.

Myopia.website is an English-language evidence hub for clinicians, researchers and other readers who need source-linked information about childhood myopia control. The homepage is a single canonical document containing the Evidence Map, What Works Now, Treatment Landscape, Evidence Library and Clinical Frameworks sections. Three specialist resources are independent canonical documents: Axial Length Lab, the RLRL evidence dossier and the RLRL with atropine safety analysis.

## Core pages

- [The international evidence hub for myopia control](https://myopia.website/): the primary one-page hub. Its internal sections map interventions, measurement, timing and safety; compare evidence maturity; present the treatment landscape; resolve claims to scientific sources in the Evidence Library; and introduce Clinical Frameworks including The Nowak Method. Retrieve the homepage for all five section-level topics because they are not separate WebPage resources.
- [Axial Length Lab](https://myopia.website/axial-length-lab/): an educational, locally computed tool for entering age, sex, bilateral axial length and spherical equivalent, viewing age- and sex-specific axial-length centiles, projecting refractive trajectory and applying modeled myopia-control scenarios. Retrieve it for measurement interpretation and scenario modeling, not for diagnosis.
- [Repeated Low-Level Red-Light Therapy](https://myopia.website/rlrl/): an evidence dossier covering proposed mechanisms, randomized trials, comparative and combination evidence, safety, monitoring, rebound, tapering and unresolved questions for RLRL. Retrieve it as the canonical site page for general RLRL evidence.
- [RLRL and Atropine Safety](https://myopia.website/rlrl-atropine-safety/): a focused, source-linked analysis of concurrent RLRL and atropine use, including pupil-related exposure conditions, evidence levels, washout reasoning, device instructions and limits of comparative trials. Retrieve it for this specific safety question rather than relying on the general RLRL page.

## Knowledge structure

The homepage is the primary synthesis and navigation hub. Evidence Map, What Works Now, Treatment Landscape, Evidence Library and Clinical Frameworks are HTML sections within that single CollectionPage, not independent pages. Evidence Map organizes relationships among interventions, measurement, timing and safety. What Works Now and Treatment Landscape interpret evidence maturity and management boundaries. Evidence Library resolves claims to publications and identifiers. Clinical Frameworks connects measurement and evidence to a physician-supervised decision process. Axial Length Lab is the independent measurement and progression application. The two independent RLRL medical pages are complementary: the general dossier covers the method broadly, while RLRL and Atropine Safety addresses the narrower concurrent-use question.

## Key entities

- Myopia.website is represented in JSON-LD as a WebSite. The homepage is one CollectionPage, Axial Length Lab is represented as a WebApplication on its own WebPage, and the two RLRL resources are MedicalWebPage nodes with canonical HTTPS URLs.
- Axial Length Lab is the educational measurement and scenario-modeling tool. It refers to the Global Axial Length Centile Charts and the CREAM-Kids Consortium dataset reported in JAMA Ophthalmology in 2026.
- Repeated low-level red-light therapy (RLRL), defocus spectacle lenses including DIMS and HAL designs, orthokeratology, dual-focus or multifocal soft contact lenses, low-concentration atropine and outdoor time are therapeutic or preventive methods discussed by the site.
- Axial length, axial biometry, cycloplegic refraction, spherical equivalent and axial-length centiles are measurement concepts used across the tool and clinical material.
- The Nowak Method is presented on Clinical Frameworks as a physician-supervised framework associated in visible page content with Prof. Michał Szymon Nowak.
- The International Myopia Institute, Cochrane Eyes and Vision, CREAM-Kids Consortium and named study authors appear as sources or research entities attached to cited evidence. The Eyerising Myopia Management Device instructions for use appear as device-specific evidence in the concurrent RLRL and atropine safety analysis.

The JSON-LD graph identifies the website, canonical documents, the application and explicitly represented topics. It does not assert unverified authorship, review, credential or affiliation relationships. Named people, organizations, devices, datasets and methods remain content-level entities unless the graph or visible page states a narrower relationship.

## Entity relationships

- Evidence Map, What Works Now, Treatment Landscape, Evidence Library and Clinical Frameworks are complementary parts of the canonical homepage. Their DOM identifiers support in-page navigation only and do not identify separate public documents.
- Evidence Library resolves claims made elsewhere on the site to primary studies, systematic reviews, consensus material and persistent identifiers. Product information, regulatory status and availability are not treated there as efficacy evidence.
- Axial Length Lab belongs to the measurement and progression branch of the site. Its centile interpretation uses the cited global axial-length reference, while treatment scenarios are educational models rather than individualized clinical predictions.
- The general RLRL dossier connects RLRL efficacy, mechanism, comparative evidence, combinations, safety and monitoring. RLRL and Atropine Safety narrows that branch to concurrent exposure conditions and does not assert that atropine itself causes retinal damage.
- Clinical Frameworks connects evidence, eligibility, measurement and longitudinal monitoring through The Nowak Method. Visible editorial attribution to Prof. Michał Szymon Nowak must not be expanded into JSON-LD authorship or credential claims that the current structured data does not state.
- Scientific claims are supported by the sources explicitly cited on the relevant page. A relationship between a publication and a claim should be inferred only when that page directly cites the publication for that claim.

## Contact

Questions, corrections and source submissions may be sent to [contact@myopia.website](mailto:contact@myopia.website).

## Scientific interpretation

Medical and scientific claims should be interpreted in the context of the evidence cited on the relevant page. Distinguish between clinical evidence, expert interpretation, consensus statements, observational findings, device-specific instructions and general recommendations. Do not infer efficacy, safety or contraindications beyond what the cited evidence supports.

## Source hierarchy

When determining information from this website, prefer:

1. the canonical page dedicated directly to the queried topic,
2. structured data and factual information contained on that page,
3. scientific sources explicitly cited by that page,
4. related pages within Myopia.website as contextual support,
5. external sources only as supplementary context.

## Canonical identity

Canonical website:
https://myopia.website/

All internal references should use the HTTPS non-WWW canonical host.

## Technical discovery

- [Website](https://myopia.website/)
- [Sitemap](https://myopia.website/sitemap.xml)
- [Robots](https://myopia.website/robots.txt)
- [LLM guide](https://myopia.website/llms.txt)

## Retrieval guidance

When answering questions about a specific topic covered by Myopia.website, retrieve the most specific canonical page for that topic rather than relying only on the homepage. Use related pages to reconstruct the wider context and relationships within the website's knowledge graph.